Novel treatment combining antiviral and neutralizing antibody-based therapies with monitoring of spike-specific antibody and viral load for immunocompromised patients with persistent COVID-19 infection.
第一作者:
Daiki,Wada
第一单位:
Department of Emergency and Critical Care Medicine, Kansai Medical University General Medical Center, 10-15 Fumizono-cho, Moriguchi, Osaka, 570-8507, Japan. dk0116-w@live.jp.
作者:
DOI
10.1186/s40164-022-00307-9
PMID
36085172
发布时间
2022-09-13
- 浏览0
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文


换一批



